Enterome

The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.

The companies will discover and develop microbiome-derived biomarkers, drug targets, and bioactive molecules for cancer.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.